| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 43,949 | 31,305 | 21,018 | | Cost of Revenue | 49,277 | 35,105 | 26,045 | | | Gross Profit | (5,328) | (3,800) | (5,027) | | | Operating Expenses | | Research Development | 8,125 | 8,906 | 9,374 | | Selling General and Administrative | 28,628 | 25,622 | 24,615 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (42,081) | (38,328) | (39,016) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 515 | 2,224 | 2,292 | | Earnings Before Interest And Taxes | (41,566) | (36,104) | (36,724) | | Interest Expense | 69 | 7 | 2 | | Income Before Tax | (41,635) | (36,111) | (36,726) | | Income Tax Expense | 82 | 2 | 2 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (41,717) | (36,113) | (36,728) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (41,717) | (36,113) | (36,728) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($41,717) | ($36,113) | ($36,728) |
|
1.48% Nasdaq 
Income Statement
